Radical surgery trial for advanced stomach cancer halted early
NCT ID NCT03042169
Summary
This study aimed to see if adding surgery to remove the main stomach tumor and a single metastatic site to standard chemotherapy helps patients with a limited spread of stomach cancer live longer and feel better than chemotherapy alone. It was a large, randomized Phase 3 trial, but it was terminated early after enrolling only 6 patients. The goal was to control the disease more aggressively in a carefully selected group of patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ico - Site Gauducheau - St Herblain
Saint-Herblain, France
Conditions
Explore the condition pages connected to this study.